TrialAnnals of oncology : official journal of the European Society for Medical Oncology2025

Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial.

E Felip et al.PubMed ↗Publisher ↗

No numbers read from the abstract.